Centers For Disease Control

CDC: US is biggest Rx opioid market

CDC: US is biggest Rx opioid market

By

The Centers of Disease Control reports that prescribers wrote enough painkiller prescriptions to give one bottle to every adult in the US in 2012.

Medicare to cover some hep. C screening

Patients have to be high-risk or Baby Boomers for coverage.

CDC sees declines in some diabetes complications

CDC sees declines in some diabetes complications

By

Centers for Disease Control data shows that diabetes complications including heart attack and amputation fell in the twenty years between 1990 and 2010. The bad news: the number of diagnosed diabetes patients tripled during that same time period.

Business briefs: CDC, Facebook, Shire

CDC finds that non-Medicare adults make up the majority of preventable heart attack and stroke cases; a Facebook study shows groups can influence HIV screening; and a Shire ADHD drug gets a "no" from Germany

CDC finds the sleepless and educated use Rx aids

CDC finds the sleepless and educated use Rx aids

By

The Centers for Disease Control and Prevention profiles the typical sleep aid user, and finds that eight hours does not mean consumers are sleeping without help.

J&J painkiller probe expands scrutiny of industry marketing

By

HHS is looking into how J&J marketed opioid painkiller Nucynta, adding to the firm's list of investigations and those of the industry as a whole.

HPV vaccination rates losing ground, CDC reports

By

The CDC says HPV vaccination rates are not improving. The latest data comes just as a recent report shows the vaccine cannot only help fend off cervical cancer, but throat cancers as well.

Actavis gets go-ahead to expand generic painkiller portfolio

By

The drug maker can now add five new doses to its generic Opana ER offerings.

AstraZeneca buys respiratory specialist Pearl Therapeutics

By

The drug maker eases the burden on its Symbicort franchise by scooping up Pearl for $510 million.

Belushi, Savient observe Gout Awareness Day

By

The actor and patient heads up a roundtable posted on the advocacy site CreakyJoints.

Business briefs: Pfizer, BMS, CMS, Sanofi

Pfizer cuts 136 workers loose in Ireland, BMS is investing in heart failure treatments, CMS has an official new leader, and Sanofi's iBGStar may have a competitor.

Egg-free, mercury-free flu vaccine approved

By

The FDA approved a flu vaccine that can be produced quickly, and lacks many elements that make patients skittish.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.